Top Markets
#1 Siren Siren +33.50%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +18.74%
#4 Ribbita by Virtuals Ribbita by Virtuals +18.09%
#5 Nockchain Nockchain +17.59%
#6 TRIA TRIA +17.53%
#7 PulseChain PulseChain +16.92%
#8 Velvet Velvet +16.71%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.81%
#10 Bitway Bitway +15.71%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Rank in Stocks #30951
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Share Price
$0.33274288
Market Cap
$14.92M
Change (1 day)
2.00%
Change (1 year)
-57.59%
Country
JP
Trade FunPep Company Limited (4881)

Category

Healthcare
Number of shares outstanding for FunPep Company Limited (4881)
Number of shares outstanding as of August 2026: 0
According to FunPep Company Limited latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for FunPep Company Limited (4881) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE